DNAH8 and metabolic dysfunction-associated steatohepatitis: To the best of our knowledge, this is the first report demonstrating that the reduction in FoF1–ATPase activity was accompanied by the promotion of mitochondrial PT in MASH models, as indicated by CRC (52% reduction at 3 weeks and 49% at 7 weeks in CDAHFD-fed mice (Figure 5B)).